Hadassah Medical Center (HMC)

Jerusalem 9112001

1 studies enrolling now · 3 studies all time

What they study most

AL Amyloidosis, Congenital Hyperinsulinism, Focal Epilepsy, Tonic-Clonic Seizures

Studies at this site

• An Open-label Study of XEN1101 in Epilepsy — Enrolling by invitation
• HM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI) — Running, not enrolling
• Study in Subjects With Light Chain (AL) Amyloidosis — Stopped early